Stage 4 Lung Cancer

Disease

Related News

Genomic Testing Helped Match Stage 4 Lung Cancer Patient to Rybrevant

Heather Quintana Suchan said early biomarker testing and genomic profiling identified an exon 20 mutation and helped match her to Rybrevant for stage 4 lung cancer. She said the treatment is working well with minimal side effects and is urging patients to seek personalized testing early.